BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 11, 2009
View Archived Issues
JAK2 inhibitor SB-1518 shows promise against hematological malignancies
Read More
Responses seen in CLL patients given cenersen added to chemo-immunotherapy
Read More
Phase I studies of products utilizing ImmunoGen's TAP technology presented at ASH meeting
Read More
Nabi Biopharmaceuticals begins phase I/II trial of antigens in PentaStaph vaccine
Read More
Neurocrine reports results from phase II trial of elagolix in endometriosis
Read More
Bayer Schering reports results from phase II trial of riociguat in pulmonary hypertension
Read More
Stallergenes reports 3-year results from phase III VO53.06 clinical trial of Oralair
Read More
Cytokinetics and GSK to terminate collaboration and license agreement
Read More
Actelion presents update on clinical development of ACT-128800
Read More
Sanofi-aventis and Alopexx sign collaboration agreement for human monoclonal antibody
Read More
Gruenenthal discloses novel bradykinin 1 receptor antagonists in development
Read More
CSIR claims the discovery of novel antimalaria agents
Read More
Gla formation inhibitors described by Daiichi Sankyo as anticoagulants
Read More
Arete Therapeutics presents sEH inhibitors as antihypertensives
Read More
Phase I results show oncolytic virotherapy with DWP-418 feasible, well tolerated
Read More
Tolerability and pharmacokinetic evaluations of ceftriaxone completed in ALS patients
Read More
Novel glucokinase activators discovered at Takeda
Read More
Novel PHD inhibitors presented by Janssen for anemia therapy
Read More
Banyu presents MCH-R1 antagonists for treatment of obesity and diabetes
Read More
Sangart initiates phase IIa study of oxygen therapeutic agent MP-4OX
Read More
Mologen applies for phase II clinical study for cancer drug MGN-1703
Read More
RegeneRx Biopharmaceuticals reports results from phase I trial of RGN-352
Read More
Bionomics and partners to conduct phase II BNC-105 trial in mesothelioma
Read More
Oxagen completes recruitment in phase IIb dose-finding trial of OC-000459 in asthma
Read More
Celgene to acquire Gloucester Pharmaceuticals
Read More
Amarin Neuroscience withdraws MAA for ethyl eicosapent soft gelatine capsules
Read More
Protalix Biotherapeutics submits NDA to FDA for taliglucerase alfa for Gaucher's disease
Read More